Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance? - Axogen ( NASDAQ:AXGN ) , Boston Scientific ( NYSE:BSX )
QIAGEN N.V. QGEN announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, a leading vaccines and diagnostics supplier to the Brazilian Ministry of Health.
| Ticker |
Sentiment |
Impact |
|
AXGN
|
Neutral
|
9 %
|
|
BSX
|
Neutral
|
9 %
|
|
QGEN
|
Somewhat Bullish
|
37 %
|
